Medicare Enrolled
Dr. Madaiah Revana, MD PA
Interventional Cardiology · Humble, TX
Practice pattern: Clinical Cardiology— Primarily office-based clinical cardiology
Speaking/Promotional
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Revana from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Revana? Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Revana
Dr. Madaiah Revana is an interventional cardiology in Humble, TX, with 20 years in practice. Based on federal Medicare data, Dr. Revana performed 5,024 Medicare services across 2,148 unique beneficiaries.
Between the years covered by Open Payments, Dr. Revana received a total of $135,321 from 58 pharmaceutical and/or device companies across 999 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in interventional cardiology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Revana is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice▲ Top 13% volume in TX$ $135,321 industry payments
Medicare Practice Summary
Medicare Utilization ↗5,024
Medicare services
Top 13% in TX for interventional cardiology
2,148
Unique beneficiaries
$92
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~251 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) | 677 | $94 | $150 |
| Management using the results of remote vital sign monitoring per calendar month, each additional 20 minutes | 668 | $31 | $65 |
| Electrocardiogram (EKG), 12-lead | 561 | $10 | $21 |
| Remote patient monitoring management, 20 min/month | 457 | $38 | $79 |
| Office visit, established patient (20-29 min) | 432 | $64 | $96 |
| Remote patient monitoring device, 30 days | 403 | $37 | $95 |
| Evaluation of implantable heart and blood vessel monitoring system, remote up to 30 days | 226 | $20 | $32 |
| Echocardiogram, transthoracic | 217 | $146 | $268 |
| Ultrasound study of arm or leg veins with compression and maneuvers | 141 | $146 | $237 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 136 | $50 | $94 |
| Technetium tc-99m tetrofosmin, diagnostic, per study dose | 135 | $36 | $48 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 131 | $351 | $2,100 |
| Remote pacemaker monitoring, 90 days | 98 | $23 | $33 |
| Ultrasound study of one arm or leg veins with compression and maneuvers | 70 | $92 | $143 |
| Chemical destruction of first incompetent vein of arm or leg using imaging guidance | 65 | $1,319 | $2,318 |
| Ultrasound of leg arteries or artery grafts | 57 | $188 | $319 |
| Injection of chemical agent into single incompetent vein of leg using ultrasound guidance | 49 | $1,066 | $1,607 |
| New patient office visit (45-59 min) | 48 | $112 | $175 |
| Heart rhythm recording, analysis, report, review, and interpretation of continous external ekg over more than 48 hours up to 7 days | 43 | $183 | $1,000 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system | 43 | $40 | $59 |
| Injection, dipyridamole, per 10 mg | 42 | $3 | $75 |
| Ultrasound of both sides of head and neck blood flow | 41 | $149 | $235 |
| Telephone medical discussion with physician, 11-20 minutes | 41 | $57 | $95 |
| Telephone medical discussion provided by nonphysician professional, 5-10 minutes | 40 | $9 | $14 |
| Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | 37 | $19 | $25 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 24 | $10 | $55 |
| Test to measure expiratory airflow and volume changes before and after medication administration | 22 | $30 | $83 |
| Regadenoson injection (Lexiscan) for heart stress test | 20 | $35 | $225 |
| Ultrasonic guidance for blood vessel access | 18 | $11 | $19 |
| Electrocardiogram (ecg) up to 30 days continuous with transmission of patient triggered events with review and report by health care professional | 17 | $668 | $1,025 |
| Heart rhythm recording, analysis, interpretation and report of continous external ekg over more than 1 week up to 1 weeks | 17 | $213 | $1,000 |
| Influenza vaccine, quadrivalent, preservative free, 0.5 ml dosage | 16 | $22 | $30 |
| Electrocardiogram (ecg) up to 30 days continuous with review and report by health care professional | 16 | $21 | $75 |
| Flu vaccine administration | 16 | $31 | $49 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
7.1% high complexity
15.0% medium
77.9% routine
Industry Payment Transparency
Open Payments through 2024 ↗$135,321
Total received (2018-2024)
Avg $19,332/year across 7 years
Top 5% in TX for interventional cardiology
58
Companies
999
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$99,239 (73.3%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$35,732 (26.4%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$350 (0.3%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024$6,508
2023$6,049
2022$10,821
2021$12,942
2020$11,546
2019$41,338
2018$46,118
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Janssen Pharmaceuticals, Inc
$74,077
Amarin Pharma Inc.
$18,842
Novartis Pharmaceuticals Corporation
$7,369
Abbott Laboratories
$7,335
BIOTRONIK INC.
$5,246
Medtronic, Inc.
$4,039
Medtronic Vascular, Inc.
$2,579
BOSTON SCIENTIFIC CORPORATION
$2,424
Bard Peripheral Vascular, Inc.
$2,093
Venclose Inc.
$1,722
Boston Scientific Corporation
$1,532
Impulse Dynamics (USA) Inc.
$754
SANOFI-AVENTIS U.S. LLC
$581
Boehringer Ingelheim Pharmaceuticals, Inc.
$460
Esperion Therapeutics, Inc.
$427
Lexicon Pharmaceuticals, Inc.
$385
Beckman Coulter, Inc.
$350
Merck Sharp & Dohme LLC
$348
Novo Nordisk Inc
$342
Amgen Inc.
$337
Actelion Pharmaceuticals US, Inc.
$333
HeartFlow, Inc.
$307
Tactile Systems Technology Inc
$287
Philips Electronics North America Corporation
$281
AstraZeneca Pharmaceuticals LP
$280
E.R. Squibb & Sons, L.L.C.
$212
Bayer HealthCare Pharmaceuticals Inc.
$200
Recor Medical Inc
$149
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$148
Biocompatibles, Inc.
$144
Azurity Pharmaceuticals, Inc.
$133
PFIZER INC.
$129
Relypsa, Inc.
$128
Avinger Inc.
$125
Arineta, Inc
$124
ARALEZ PHARMACEUTICALS US INC.
$107
Gilead Sciences, Inc.
$105
Janssen Scientific Affairs, LLC
$102
Regeneron Healthcare Solutions, Inc.
$99
ARBOR PHARMACEUTICALS, INC.
$99
Bayer Healthcare Pharmaceuticals Inc.
$95
BARD PERIPHERAL VASCULAR, INC.
$58
AngioDynamics, Inc.
$50
Kestra Medical Technology Services, Inc.
$49
Vifor Pharma, Inc.
$47
ABIOMED
$46
Aziyo Biologics, Inc.
$36
Merck Sharp & Dohme Corporation
$31
Alnylam Pharmaceuticals Inc.
$23
Edwards Lifesciences Corporation
$23
Cardiovascular Systems Inc.
$23
GlaxoSmithKline, LLC.
$20
Arbor Pharmaceuticals, Inc.
$17
NormaTec Industries, LP
$16
Coala Life Inc
$15
Cook Medical LLC
$14
SCPHARMACEUTICALS INC.
$13
Althera Pharmaceuticals LLC
$12
Top 3 companies account for 74.1% of total payments
Associated products mentioned in payments ›
ANORO ELLIPTA · ASSURITY · AURYON LASER SYSTEM 100-120 VAC · AVEIR · Accent Pacemaker · Acticor · Assure WCD · BIOMONITOR · BRILINTA · CHANTIX · CLOSUREFAST · CONFIRM RX · COOK CELECT · COREVALVE EVOLUT R · CRT Leads · CRT-Ds · CardioGraphe · ClosureFast · Coala Heart Monitor · Confirm Rx · Connectivity and Remote care · CoreValve Evolut · Corlanor · DXI 800 · ECM Patch · EDARBI · ELIQUIS · ENTRESTO · EVRSF · Edarbi · Edarbyclor · Endurant · Ensite Cardiac Mapping System · FARXIGA · FFRct · FLEXITOUCH · FUROSCIX · Flexitouch Plus · GENERAL ANGIOPLASTY · GENERAL ATHERECTOMY · General - Vascular Access · HORIZANT · HeartMate 3 Left Ventricular Dev · IGT D Peripheral · IGT_D Peripheral · IN.PACT Admiral · Impella · Inpefa · JANUVIA · JARDIANCE · JOT DX · Kerendia · LEQVIO · LifeVest · MULTAQ · Merlin Connectivity and Remote · MitraClip System · NEXLETOL · ONPATTRO · OPSUMIT · OPTIMIZER · Optimizer · Ozempic · PANTHERIS · PARADISE RENAL DENERVATION SYSTEM · PRADAXA · PRALUENT · PRALUENT ALIROCUMAB INJECTION · Pacemakers · Peripheral Orbital Atherectomy System · Pouch · Quadra Allure MP RF CRT Pacemkr · Quadra Assura CRT Defibrillator · Quartet CRT Lead · REVEAL LINQ · Renamic Neo · Repatha · Reveal LINQ · Roszet · Rybelsus · Solia · TurboHawk · UPTRAVI · VARITHENA · VENASEAL · VENOVO · VERQUVO · VYNDAQEL · Varithena Administration Pack · Vascepa · Veltassa · VenaSeal · Venclose · Venclose Maven Catheter · Verquvo · Via · WATCHMAN · WATCHMAN Access System · WATCHMAN FLX · XARELTO · ZONTIVITY
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (73%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in interventional cardiology and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 5% for interventional cardiology in TX.
Equivalent to $2,693 per 100 Medicare services performed
Geographic Context
Interventional Cardiologys within 10 mi
55
Per 100K population
1.2
County median income
$73,104
Nearest hospital
MEMORIAL HERMANN NORTHEAST HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Revana is a clinical cardiology specialist, with above-average Medicare volume (top 13% in TX), and high industry engagement (speaking/promotional, top 5%), with 20 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Revana experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Revana performed 677 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Revana receive payments from pharmaceutical companies?
Yes. Dr. Revana received a total of $135,321 from 58 companies across 999 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Revana's costs compare to other interventional cardiologys in Humble?
Dr. Revana's average Medicare payment per service is $92. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Revana) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Interventional Cardiologys in Humble
Browse interventional cardiologys in Humble ranked by procedure volume and transparency data.
Highest volume
Top Interventional Cardiologys in TX
Interventional Cardiologys ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Interventional Cardiologys in TX
Which TX interventional cardiologys receive the most from drug and device companies.
By company
Janssen Pharmaceuticals, Inc Payments to Doctors
See all physicians who received payments from Janssen Pharmaceuticals, Inc.
By company
Amarin Pharma Inc. Payments to Doctors
See all physicians who received payments from Amarin Pharma Inc..
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology